The AI Reckoning — The Pharma Closeout
The Pharma Closeout Research

The AI
Reckoning

The operational intelligence your AI strategy is missing.

169 pages. 63 use cases. Built by pharma operators, not consultants.

Get the Free Briefing → Get the Full Compendium — $149
The Podcast Series
Alex Mercer and Maya Patel unpack who's actually capturing AI value in pharma — and who's still running pilots that go nowhere. Four episodes.
The Strategic Briefing
The 28-page executive summary. Crisis, opportunity, and a 180-day action roadmap for your leadership team — delivered to your inbox.
The Definitive Compendium
The operational intelligence your AI strategy is missing. Case studies, diagnostic scorecard, and proprietary frameworks built for pharma leadership teams.
Who This Is For

Built for pharma leaders who are done with AI hype.

Commercial Leaders
Translate AI capabilities into franchise strategy and competitive advantage.
Strategy & Operations
63 use cases mapped to real pharma workflows, not vendor demos.
C-Suite & Board
The evidence base for your next AI investment decision.
Special 4-Part Series

The AI Reckoning — Listen Free

Alex Mercer and Maya Patel go deep on the data behind the Compendium. Four episodes. No filler. The real competitive landscape for AI in pharma.

1
The Reckoning
89% of scientists already use AI as their first stop. But only a fraction of companies are capturing real competitive value. The separation is happening now.
28 min +
2
From Molecule to Market
173 AI-discovered drug programs in clinical development. First FDA approval projected within 18 months.
30 min +
3
The Agentic Enterprise
74% of pharma planning agentic AI deployment. Novo cut forecast errors 50%. The operations revolution is underway.
30 min +
4
Who Wins
Three AI strategies emerge. Winners integrate across discovery + operations + talent simultaneously.
32 min +

The Strategic Briefing

28 pages. The crisis, the opportunity, and a 180-day action roadmap for pharma leadership teams — distilled from the full Compendium.

  • The $275B revenue cliff and why AI is the only lever at scale
  • The Cascade Framework — where to start and what to prioritize
  • Three case studies compressed into actionable lessons
  • A 180-day action roadmap your leadership team can use Monday
Download the Briefing
Free PDF. Enter your email at checkout and download instantly.
Get the Free Briefing →

Powered by Gumroad. Your email is collected for delivery only.

Built by The Pharma Closeout's research team — pharma operators, not consultants.

169 Pages 63 Use Cases 60+ Primary Sources 30-Question Diagnostic
The Full Research

AI in Pharma:
The Definitive Compendium

Everything in the Briefing — plus 140 more pages of original analysis, operational frameworks, and the evidence base your strategy deck is missing.

63
GenAI Use Cases
Mapped across discovery, trials, operations, and commercial — with implementation evidence for each
3
Deep Case Studies
Pfizer's $750M AI platform · Recursion-Exscientia $712M · UCB & Novo Nordisk commercial excellence
30
Question Diagnostic
The Cascade Scorecard — 5 questions per link, benchmarking your organization's AI maturity
180
Day Action Framework
12 imperatives with governance structure. A ready-to-present roadmap for your leadership team
Part I — The Crisis
The AI Reckoning
$275B in revenue at risk. Why the next 36 months determine which companies survive the patent cliff.
Part II — The Technology
From Molecule to Market
AI across the full value chain — discovery, clinical trials, operations, and the 63 commercial GenAI use cases.
Part III — The Transformation
Workforce, Governance, Action
The AI-augmented workforce. The governance imperative. 12 strategic imperatives for the next 180 days.
Appendices
The Evidence Base
AI ecosystem map, 354 curated statistics across 6 domains, source document index, full glossary.
Free Briefing
28 pages
The overview
Full Compendium
169 pages
The playbook
$197 $149 Launch Price
Launch pricing ends
Get the Compendium → PDF · 169 pages · Instant delivery · Secure checkout via Gumroad
Proprietary Framework

The Cascade Framework

The 6-link AI maturity model at the heart of the Compendium. Maps value creation across the entire pharma value chain — and powers the 30-question self-assessment scorecard.

The evidence base
pharma leaders need.

63 mapped use cases. Three deep case studies. A 30-question diagnostic scorecard. A 180-day action framework. Immediate PDF delivery.

$197 $149 Launch Price
Launch pricing ends
Get the Compendium →

Secure checkout · PDF instant delivery · 60+ cited sources

Frequently Asked Questions

AI in Pharma: What You Need to Know

How is AI being used in pharmaceutical companies?
AI is being deployed across the full pharmaceutical value chain — from drug discovery and clinical trial optimization to commercial operations and market access. The Pharma Closeout's research maps 63 distinct GenAI use cases across six domains. The full mapping and implementation evidence is available in the free Strategic Briefing.
How many AI-discovered drugs are in clinical development?
As of 2026, 173 AI-discovered drug programs have entered clinical development across the pharmaceutical industry. This represents a significant acceleration from fewer than 50 programs three years ago. The Pharma Closeout's research tracks three distinct waves of AI adoption driving this growth.
What is the Cascade Framework for pharma AI maturity?
The Cascade Framework is a 6-link AI maturity model developed by The Pharma Closeout that maps value creation across the entire pharma value chain: Discover, Develop, Deliver, Commercialize, Workforce, and Governance. It powers a 30-question diagnostic scorecard for benchmarking organizational AI readiness. The full framework and scorecard are detailed in the Definitive Compendium.
What are the biggest AI use cases in pharma commercial operations?
The highest-impact commercial AI use cases in pharma include AI-driven HCP engagement, omnichannel orchestration, market access optimization, and competitive intelligence automation. The Pharma Closeout's research identifies 63 use cases across discovery, trials, operations, and commercial functions — with implementation evidence for each.
Get the free 28-page AI in Pharma briefing Download Free →